2024
TRPS1 expression in cytologic specimens of salivary duct carcinoma and other salivary gland tumors
Wang M, Cai G, Gilani S. TRPS1 expression in cytologic specimens of salivary duct carcinoma and other salivary gland tumors. Annals Of Diagnostic Pathology 2024, 74: 152406. PMID: 39547127, DOI: 10.1016/j.anndiagpath.2024.152406.Peer-Reviewed Original ResearchConceptsTRPS1 expressionSalivary duct carcinomaTrichorhinophalangeal syndrome type 1Salivary gland tumorsBreast carcinomaMucoepidermoid carcinomaSecretory carcinomaWarthin's tumorDuct carcinomaGland tumorsSalivary duct carcinoma casesCase of secretory carcinomaAcinic cell carcinomaAdenoid cystic carcinomaBasal cell adenomaImmunophenotypic featuresCystic carcinomaSurgical specimensCell adenomaCell carcinomaCytology casesCytology specimensPleomorphic adenomaCell blocksBreast cancer
2022
Microsecretory adenocarcinoma: Cutaneous counterpart of a newly described salivary gland tumor with recurrent MEF2C::SS18 fusion
Panse G. Microsecretory adenocarcinoma: Cutaneous counterpart of a newly described salivary gland tumor with recurrent MEF2C::SS18 fusion. Journal Of Cutaneous Pathology 2022, 50: 188-190. PMID: 36308392, DOI: 10.1111/cup.14349.Commentaries, Editorials and LettersConceptsMicrosecretory adenocarcinomaSalivary gland tumorsGland tumorsLow-grade salivary gland tumorsHigh-grade featuresComplete surgical excisionUnique immunohistochemical profileMicrocystic tubulesCutaneous counterpartFibromyxoid stromaLocal recurrenceSurgical excisionHistopathological featuresIndolent tumorsImmunohistochemical profileClear cytoplasmUnique tumorOral cavityLuminal secretionsAccurate diagnosisTumorsSkinMolecular studiesVast majorityAdenocarcinoma
2021
Comprehensive Genomic Characterization of A Case of Granular Cell Tumor of the Posterior Pituitary Gland: A Case Report
Hong CS, Elsamadicy AA, Fisayo A, Inzucchi SE, Gopal PP, Vining EM, Erson-Omay EZ, Omay S. Comprehensive Genomic Characterization of A Case of Granular Cell Tumor of the Posterior Pituitary Gland: A Case Report. Frontiers In Endocrinology 2021, 12: 762095. PMID: 34925233, PMCID: PMC8671743, DOI: 10.3389/fendo.2021.762095.Peer-Reviewed Original ResearchConceptsGranular cell tumorPosterior pituitary glandCell tumorsPituitary glandComprehensive genomic characterizationWhole-exome sequencingImmune checkpoint inhibitorsPoor clinical outcomePituitary gland tumorsHistone deacetylase inhibitorsInstitutional review boardRadiographic compressionUnderwent resectionCheckpoint inhibitorsMedical therapyPituitary massClinical outcomesOptic nerveSignificant morbidityResidual diseaseCase reportCentral hypothyroidismPharmacologic agentsGland tumorsTherapeutic targetingOutcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy
Zakeri K, Wang H, Kang JJ, Lee A, Romesser P, Mohamed N, Gelblum D, Sherman E, Dunn L, Boyle J, Wong R, Chen L, Yu Y, Tsai CJ, McBride SM, Riaz N, Lee N. Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. Head & Neck 2021, 43: 1056-1062. PMID: 33606323, PMCID: PMC9371938, DOI: 10.1002/hed.26563.Peer-Reviewed Original ResearchConceptsMajor salivary gland tumorsProton beam radiation therapyBeam radiation therapySalivary gland tumorsRadiation therapyLocoregional controlGland tumorsProgression-free survivalPhoton radiation therapyOverall survivalPrognostic factorsCommon siteCystic carcinomaLarge cohortDosimetric advantagesParotid glandTherapyPatientsTumorsTherapy CenterSurvivalTreatmentProton Therapy CenterCarcinomaCohort
2019
Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors
Torabi SJ, Spock T, Cardoso B, Chao J, Manes RP, Judson BL. Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors. Journal Of Neurological Surgery Part B Skull Base 2019, 81: 198-205. PMID: 32206540, PMCID: PMC7082160, DOI: 10.1055/s-0039-1683437.Peer-Reviewed Original ResearchMinor salivary gland tumorsSalivary gland tumorsTriple-modality therapyGland tumorsModality therapyMultimodality treatmentPositive marginsTreatment modalitiesSubset analysisNational Comprehensive Cancer Network guidelinesClinical American Joint CommitteeNational Cancer DatabaseMulti-modality treatmentOnly treatment modalityAmerican Joint CommitteeMost treatment modalitiesAdjuvant chemoradiotherapySurvival benefitSurgical managementNetwork guidelinesCancer DatabaseChemoradiotherapyCommon treatmentSurgeryJoint CommitteeNonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery
Torabi SJ, Cheraghlou S, Kasle DA, Savoca EL, Judson BL. Nonsquamous cell laryngeal cancers: Incidence, demographics, care patterns, and effect of surgery. The Laryngoscope 2019, 129: 2496-2505. PMID: 30632157, DOI: 10.1002/lary.27785.Peer-Reviewed Original ResearchConceptsEffect of surgeryNon-SCC patientsNeuroendocrine tumorsLaryngeal cancerClinical profileMinor salivary gland tumorsClinical M stageNon-SCC cohortSpecific surgical methodsNational Cancer DatabaseMajority of patientsMajor histological subtypesSalivary gland tumorsAdult patientsImproved survivalTreatment regimenDistant metastasisWorse prognosisHistological subtypesCancer DatabaseLaryngeal carcinomaSurgical methodsRetrospective analysisGland tumorsSurgery
2018
NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018.
Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, Heslin MJ, Kalemkerian GP, Kandeel F, Khan SA, Kidwai WZ, Kunz PL, Kuvshinoff BW, Lieu C, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Sussman CA, Trikalinos NA, Uboha NA, Whisenant J, Wong T, Yao JC, Burns JL, Ogba N, Zuccarino-Catania G. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal Of The National Comprehensive Cancer Network 2018, 16: 693-702. PMID: 29891520, DOI: 10.6004/jnccn.2018.0056.Peer-Reviewed Original ResearchConceptsPrimary neuroendocrine tumorNeuroendocrine tumorsAdrenal tumorsManagement of NETsLocoregional advanced diseaseNCCN Guidelines InsightsAdrenal gland tumorsAdvanced diseaseNCCN guidelinesAdult patientsDistant metastasisGastrointestinal tractGland tumorsTumorsNeuroendocrineManagement optionsGuidelinesPatientsPheochromocytomaMetastasisParagangliomaDiseaseTract
2014
Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.
Luo W, Lindley S, Lindley P, Krempl G, Seethala R, Fung K. Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature. International Journal Of Clinical And Experimental Pathology 2014, 7: 9008-22. PMID: 25674280, PMCID: PMC4313953.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkers, TumorBiopsyBreast NeoplasmsCarcinomaCranial IrradiationFemaleHumansImmunohistochemistryLymphatic MetastasisMagnetic Resonance ImagingNeoplasm GradingOncogene Proteins, FusionPalatal NeoplasmsPalate, HardRadiotherapy, AdjuvantRecombination, GeneticSalivary Gland NeoplasmsTomography, X-Ray ComputedTreatment OutcomeConceptsHigh-grade histologyMinor salivary glandsETV6-NTRK3 translocationSalivary gland tumorsParotid glandSalivary glandsGrade histologySecretory carcinomaHard palateOriginal tumorGland tumorsCervical lymph node metastasisMammary analogue secretory carcinomaPrimary salivary gland tumorsLow histologic gradeLymph node metastasisLow-grade malignancyAcinic cell carcinomaYears of ageHigh-grade transformationYear old adultsReview of literatureOverall prognosisBenign courseNode metastasis
2000
Myoepithelial Carcinoma of the Salivary Glands
Savera A, Sloman A, Huvos A, Klimstra D. Myoepithelial Carcinoma of the Salivary Glands. The American Journal Of Surgical Pathology 2000, 24: 761-774. PMID: 10843278, DOI: 10.1097/00000478-200006000-00001.Peer-Reviewed Original ResearchConceptsMyoepithelial carcinomaMalignant mixed tumorMixed tumorsImmunohistochemical profileSalivary gland carcinomasEpithelial membrane antigenMuscle-specific actinSalivary gland tumorsHigh-power fieldsDiverse clinical outcomesEvidence of diseaseSmooth muscle actinBenign mixed tumorS-100 proteinGlial fibrillary acidic proteinFibrillary acidic proteinTen tumorsPainless massCytokeratin 7Cytomorphologic featuresGland tumorsClinicopathological featuresMembrane antigenClinical behaviorVascular invasion
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply